Hi-Tech Pharmaceuticals Invests Into Expanding and Automating Production of Phosphagen™ Brand Creatine to Keep Pace with the Growing Demand for High Quality Creatine

NORCROSS, Ga., Sept. 21, 2026 /PRNewswire/ -- Hi-Tech Pharmaceuticals, Inc., today announced an additional capacity to produce Phosphagen™, the world's most trusted creatine brand Creatine Monohydrate. Phosphagen™ was released in 1993 by Experimental and Applied Sciences (EAS), a subsidiary of Hi-Tech today. This marked the first time creatine was made available to the public. Phosphagen™ is widely recognized as the "gold standard" of creatine monohydrate due to its stringent quality control and specialized synthesis process.

Phosphagen™ creatine is a unique form of creatine monohydrate that is considered by many to be one of the best-quality forms of micronized creatine currently available for purchase. Phosphagen™ undergoes a unique manufacturing process in which it is turned into an even purer form of creatine, providing users with more pure creatine per serving. This means that it is free from additional impurities and ingredients that are commonly found in regular creatine supplements. Most general creatine supplements are around 97–99% pure, Phosphagen™ creatine is at least 99.99% pure. Unlike generic creatine monohydrate, which may come from various sources with varying levels of purity, Phosphagen™ is produced in a dedicated facility under strict quality control, ensuring minimal impurities like creatinine, dicyandiamide, and dihydrotriazine.

Hi-Tech Pharmaceuticals, Inc., a vertically integrated Branded Sports Nutrition Company and specialty chemicals and dairy supplier with a leading market position in selected niche markets, is experiencing sustained high demand for its Phosphagen™ product, the world's purest creatine monohydrate, which is used as a dietary supplement in sports nutrition. Against this background, the company has decided to significantly increase its production capacity for creatine monohydrate and to take advantage of additional opportunities in the market by expanding its production facility for the precursors of creatine monohydrate.

"With our current investments, we will achieve significantly profitable growth. We will leverage of our strong position in the premium creatine segment of the sports and health market. Likewise, we will benefit noticeably from our unique position as the originator and quality leader of creatine," explains Jared Wheat, CEO of Hi-Tech Pharmaceuticals.

The sports and health market is a growth market that has grown significantly in recent years. Sports nutrition is increasingly expanding from competitive sports to users who focus on fitness and a healthy lifestyle. Creatine research has also expanded beyond sports performance. Emerging areas include: Brain Health and Cognition, Longevity and aging research, Women's health, and Neuroprotection. Accordingly, marketing activities for Phosphagen™ are increasingly being extended to these users. Until manufacturing capacity increases periodic shortages of premium creatine shortages like Phosphagen™ may continue.

About Hi-Tech Pharmaceuticals

Hi-Tech Pharmaceuticals (https://www.hitechpharma.com/index.htm) is a leading Sports Nutrition manufacturer. Since 1979, Hi-Tech Pharmaceuticals, Inc. and its sister company, Hi-Tech Nutraceuticals, LLC. have been providing quality custom manufacturing services to the pharmaceutical, dietary supplement and beverage industries. Hi-Tech Pharmaceuticals is a cGMP certified company that operates out of Four (4) US Production facilities and (3) Warehouses, totally over 500,000 sq. ft. The two Georgia based production facilities are both located outside Atlanta in the Norcross and Suwanee Advanced Technology areas. Hi-Tech also has Two (2) facilities located outside State College, Pennsylvania. Hi-Tech holds a Drug Manufacturing License issued by the State of Pennsylvania Food and Drug Branch and is registered as a Food and Drug Establishment with the FDA in Pennsylvania.

Hi-Tech Pharmaceuticals is an enormously successful company that creates, manufactures and sells high-quality products sold by the large, major retailers across the United States.

Media Contact:
Michelle Harris
770-797-9959
[email protected]

SOURCE Hi-Tech Pharmaceuticals, Inc.